{
  "id": "new-cagrisema-data-show-improvement-over-semaglutide",
  "title": "New CagriSema data show improvement over semaglutide",
  "content": "Novo Nordiskâ€™s next-gen metabolic drug CagriSema performed better than the blockbuster semaglutide at reducing blood sugar and weight in patients with type 2 diabetes.\n\n That was the topline result from the latest Phase 3 readout ...",
  "author": "Max Bayer",
  "source": "endpoints",
  "category": "R&D, Pharma",
  "published_at": "Mon, 02 Feb 2026 19:16:29 +0000",
  "url": "https://endpoints.news/new-cagrisema-data-show-improvement-over-semaglutide/",
  "scraped_at": "2026-02-03T11:28:06.295369"
}